Clinical Trial

Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multicentre, non-inferiority randomized controlled trial to compare the efficacy and safety of 14-day vonoprazan-based dual therapy with versus quadruple therapy for the eradication of Helicobacter pylori. The primary outcome is eradication rate, and the secondary outcome includes the incidence of adverse events and compliance.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-10; most recent amendment 2026-04-14.
Status change: Not Yet Recruiting → Recruiting 2026-03-09
Trial Details
NCT Number NCT07179159
Lead Sponsor Yanqing Li
Collaborators: Longkou People's Hospital, Qingdao Jimo People's Hospital, Shandong University of Traditional Chinese Medicine, Dezhou Hospital Qilu Hospital of Shandong University, Zibo Maternal and Child Health Hospital, Guanxian County People's Hospital, Yantai Zhifu Hospital, Dongying No. 2 People's Hospital, Qilu Hospital of Shandong University
Conditions HELICOBACTER PYLORI INFECTIONS
Enrollment 372 participants
Start Date 2025-09-09
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-15